(Date:11/9/2009)..., , BIRMINGHAM, Ala. The U.S. Department of Ener...he University of Alabama at Birmingham (UAB) Schoo...educe greenhouse gas emissions through the capture...carbon dioxide (CO2). The project is in collaborat...labama Power. , Funded by the DOE through the 20...
(Date:11/9/2009)..., The brilliance of butterfly wings has inspire...s to deliver innovation in the fields of security,...ter and international technology company QinetiQ h...p new technologies based on groundbreaking physica...s a team of physicists from the University of Exet...
(Date:11/9/2009)..., PHILADELPHIA Scientists and industry leaders f...-19, 2009, for the AACR-NCI-EORTC Molecular Target..., which will feature groundbreaking information on...Cancer is a complex disease and to treat it effect...ity that takes place at the molecular level," said...
Breaking Biology News(10 mins):UAB, partners seek safe carbon dioxide storage for 'greener' power generation 2UAB, partners seek safe carbon dioxide storage for 'greener' power generation 3£3.2m ($5.4 million) research project to capture brilliance of butterfly wings 2Nuvilex Introduces Last Shot Hangover Remedy 28TM 29 Video 55546 1Nuvilex Introduces Last Shot Hangover Remedy 28TM 29 Video 55546 2The Cosmetic Bootcamp LLC Announces Novel Presentations at Its 3rd Annual Marketing and Management Symposium 55542 1White House Sued Over Free Speech Violations In Healthcare Battle 3A Doctor 26 Patient Groups Say White House Intended to Shut Up Opponents 55538 1White House Sued Over Free Speech Violations In Healthcare Battle 3A Doctor 26 Patient Groups Say White House Intended to Shut Up Opponents 55538 2(Date:11/6/2009)... Nov. 6 Intarcia Therapeutics, Inc...0 (DUROS® continuous delivery of exenatide) p... Ninth Annual Diabetes Technology Meeting in San F.../cgi-bin/prnh/20050301/SFTU126LOGO ) ,, Conti...650 Lowers Plasma Glucose, HbA1c and Reduces Weigh...
(Date:11/5/2009)...., Nov. 5 GenVec, Inc. (...lts for the third quarter ended September 30, 2009...4 per share) for the three months ended September ...0.08 per share) in the comparable quarter of 2008....Vec,s net loss was $14.1 million ($0.15 per share)...
(Date:11/5/2009)...5 Imagenetix, Inc. (OTC ...m Spencer, President and CEO of Imagenetix, will b... LD MICRO Conference on Thursday, December 3rd, at..., About LD MICRO ,, LD MICRO is a by-invitat...ndervalued companies in the micro-cap space. Since...
(Date:11/5/2009).... 5 Transgenomic, Inc. (...l results for the quarter ended September 30, 2009... the tables that follow. ,, Third Quarter 2009...0 or $0.01 per share for the third quarter of 2009...r share for the third quarter of 2008. ,, Net ...
Breaking Biology Technology:Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7...,(Nasdaq: MAXY ), a biotechnology company focused...ay announced that it will present at the,JPMorgan ...ry 7, 2008 at,9:00 a.m. Pacific Time. Russell Howa...Vetticaden, Maxygen,s chief medical officer, will ... accessed on Maxygen,s website at, http://www.maxy...
...ber 28, 2007 at 8:30 a.m ...xza,Pharmaceuticals, Inc. (Nasdaq: ALXA ) today a...opment partnership with Endo Pharmaceuticals Holdi...fentanyl) and the fentanyl,class of molecules for ...opment, AZ-003 is a hand-held drug device that use...
...Science from Faux Science, NORTH KINGSTOWN, R.I.,...Society, Dominion Diagnostics sponsored an extensi...eview of Urine Drug Testing:,Which Test, Which Pat...ence," presented by Dr. Robert Barkin, Pharm.D, MB...r, Faculty of Anesthesiology, Family,Medicine, and...
Other Biology Technology:Alexza Announces Partnership With Endo for AZ-003 (Staccato(R) fentanyl) in North America 2Alexza Announces Partnership With Endo for AZ-003 (Staccato(R) fentanyl) in North America 3Alexza Announces Partnership With Endo for AZ-003 (Staccato(R) fentanyl) in North America 4Alexza Announces Partnership With Endo for AZ-003 (Staccato(R) fentanyl) in North America 5Arizona Pain Society and Dr. Robert Barkin, Rush University Medical Center, Present Program on Comprehensive Urine Drug Testing Sponsored by Dominion Diagnostics 2RNA oligos ready-to-use from Thermo Scientific
...m7G(5')ppp(5')G (Cap Analog) is used for the synth...ription reactions. Substitution of cap analog for ...ption reaction results in the incorporation of the...ripts. Capped mRNAs are generally translated more ...
iEMS Incubator/Shaker 2 module from Thermo Scientific
...Source: Pseudomonas atlantica Description: Beta-Ag...s from low-melting-temperature agarose. Beta-Agara...es. Tested User Friendly Properties: Heat Inactiva...mum pH: 6.5 Purity: Tested for contaminating endon...
Biology Products: